Low levels of XIST in ovarian tumors indicate more M-CSCs, which are more invasive, and are more likely to cause tumors to become aggressive and metastatic, leading to a lower survival rate for patients with low XIST expression. The gene discussed is XIST; the disease is ovarian neoplasm.